Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis

Clinical trial NCT02209779 · COMPLETED

Trial details

NCT number: NCT02209779
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2001-05-01
Primary completion: 2002-06-01
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.